Comment on: Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study
Rheumatol Adv Pract
2022 Feb 17;6(2):rkac010.
Kaleen N Hayes
Andrea M Burden
Elizabeth M Winter
Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, RI, USA.
Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.
Center for Bone Quality, Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Rheumatic Disease Unit, Western General Hospital, NHS Lothian.
Rheumatology and Bone Disease Unit, Centre for Genomic and Experimental Medicine Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
No abstract available